QA: Celldex Therapeutics Inc. in us_medicinal_products/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000744218_2019_Celldex_Therapeutics_Inc.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0000744218, Celldex Therapeutics Inc.

  xvar xval
0 LiabilitiesNoncurrent 19,147,000
1 LiabilitiesCurrent 12,602,000
2 remainder_Liabilities 0
3 AssetsCurrent 99,079,000
4 AssetsNoncurrent 1,929,000
5 PropertyPlantAndEquipmentNet 6,111,000
6 Goodwill 48,690,000
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 19,269,000
9 ResearchAndDevelopmentExpense 66,449,000
10 remainder_Expenses 79,491,000
11 remainder_Revenues 14,025,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 19,000
  yvar yval
0 Liabilities 31,749,000
1 Assets 155,809,000
2 Expenses 165,209,000
3 Revenues 14,025,000
4 StockholdersEquity 124,060,000
5 NetIncome -151,184,000
6 ComprehensiveNetIncome -151,174,500
7 BaseVar 183,405,500
8 EconomicCapitalRatio -0.488

Edgar->Model Mapping

Feature Distribution

Change over Time